Detalhe da pesquisa
1.
Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group.
Diabetes
; 46(3): 433-9, 1997 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-9032099
2.
Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes. The Troglitazone Study Group.
Diabetes Care
; 21(9): 1462-9, 1998 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-9727892
3.
Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group.
J Clin Endocrinol Metab
; 83(9): 3169-76, 1998 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-9745421
4.
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial.
J Clin Endocrinol Metab
; 86(4): 1626-32, 2001 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11297595
5.
Continuous on-line hydrogen ion monitoring to study flow dynamics of perifusion systems and cellular metabolism.
Am J Physiol
; 266(5 Pt 1): E739-49, 1994 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-8203513
6.
The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.
Ann Intern Med
; 134(9 Pt 1): 737-45, 2001 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11329231